Back to search

National and Kapodistrian University of Athens

Μελέτη καρκινικών κυττάρων μαστού in vitro με βιοχημικές και ανοσοϊστοχημικές μεθόδους: in vitro μελέτη του ρόλου της ιντεργκρίνης ανβ3 στην παθογένεια του καρκίνου του μαστού

Abstract

dc:description

Breast cancer is the most common cancer in women around the world. The major cause of death among breast cancer patients is the development of metastatic lesions at distant sites from the primary tumor, such as the bones, lungs, liver and brain. Metastasis is a multistage process in which cancer cells invade the surrounding connective tissue, enter the circulation and eventually extravasate and proliferate at the new site.Many of these steps involve integrins, a family of transmembrane adhesion receptors that connect the cytoskeleton to the extracellular matrix (ECM) and/or adjacent cells. Integrins comprise a family of at least 24 transmembrane heterodimers formed by the non-covalent associations between 18 alpha and 8 beta subunits. Their heterodimeric composition generally confers to ligand specificity, according to which they are classified in four classes, those that recognize collagen, laminin, the tripeptide sequence Arg-Gly-Asp (RGD), and several specific leukocyte associated ligands. Upon ligand binding, the cytoplasmic domain of the integrin beta-subunit associates with structural and signaling cytosolic proteins resulting in integrin clustering, organization of the cytoskeleton, and initiation of signaling events essential for cell adhesion, spreading, migration, proliferation, survival and differentiation.The regions of the plasma membrane where integrins connect actin cytoskeleton to ECM are specialized adhesive structures called focal contacts. Cell migration is sustained by the continuous growth of actin filaments at the leading edge, and the controlled retraction of adhesive contacts at the rear of the cell. A combination of targeted internalization/recycling and slow lateral diffusion in the plasma membrane drive integrins to the newly forming focal contacts at the leading edge of migrating cells. Recent studies describing integrin trafficking prompted proposals that the internalization of integrin heterodimers from the plasma membrane into endosomal compartments and the subsequent recycling back to the cell surface regulates cell migration and invasion.Specifically, integrin alphavbeta3 – a vitronectin receptor – binds to extracellular matrix molecules via an RGD-binding site and it has been implicated in the pathophysiology and progression of several malignant tumors, such as melanoma, glioma, ovarian, prostate and breast cancer. In breast cancer cells, high expression of activated integrin alphavbeta3 – but not that of non-activated integrin alphavbeta3 – is associated with a highly aggressive metastatic phenotype, signaling the onset of widespread metastasis.Integrin alphavbeta3-blocking strategies have been developed to treat a large number of diseases. In in vitro studies, the use of antagonists to integrin alphavbeta3, comprising RGD peptides, small molecule compounds, peptidomimetics, disintegrins and monoclonal antibodies have been employed. The RGD sequence is an important cell attachment recognition site for integrins in many ECM components. Synthetic RGD peptides can inhibit the interactions of cells with RGD-containing ECM adhesion proteins which are necessary for cell attachment and invasion through tissues.In preclinical studies, inhibition of integrin alphavbeta3 function efficiently suppressed angiogenesis and inhibited tumor progression. These encouraging preclinical results stimulated researchers and industry to develop pharmacological inhibitors of integrin alphavbeta3 function for clinical testing. However, these agents did not appear to be as successful, as it was originally hoped. In addition, most of the preclinical studies have been carried out using established breast cancer cell lines due to their easy manipulation, the infinite cell quantities and the high degree of homogeneity. However, cell lines are prone to genotypic and phenotypic alterations during their continual culture, resulting in a drift away from the phenotype of the originating tumor in vivo. On the contrary, primary cultures derived directly from tumors have the advantage that the cultured cells are directly isolated from the tumor site and their phenotype closely reflects the pathobiology of the original tumor in vivo, as cancer cells are cultured for a finite length of time and they have little opportunity to undergo genotypic transformations.Given the above, the aim of the present study was to develop an experimental model of primary cultures derived from breast biopsies to study the expression of integrin alphavbeta3 and its role in the adhesive and metastatic ability of breast cancer cells after the effect of an RGD peptide. Primary cell cultures from breast carcinoma and fibroadenoma biopsies were grown on artificial vitronectin substrate using the non enzymatic method. Vitronectin is the main ligand of integrin alphavbeta3 via the RGD sequence and it is a principal constituent of human lymph node ECM playing an important role as an initial homing molecule for metastasizing tumor cells. Specifically, in human breast carcinomas, vitronectin accumulates locally in ECM around some cancer cell clusters. The culture conditions whicj were used in this study, allowed the development of cancerous epithelial cells (~80%) as well as the controlled growth of a low number of fibroblast-like cells (~20%). The presence of the fibroblasts in the developed primary cell cultures is considered essential, resembling more closely the in vivo environment of the tumor, as they are associated with cancer cells at all stages of cancer progression and their structural and functional contributions promote the growth of mammary carcinoma cells.In the present work, the effects of synthetic linear RGD hexapeptide GRGDSP were studied, for the first time, on breast cancer tissue fragments derived directly from the primary site of tumors, as well as on well-spread human breast cancer cells from primary cultures, using the explant technique, in order to clarify the role of this peptide on the adhesion and motility of these cells through the expression of integrin alphavbeta3 and the distribution of actin cytoskeleton, affecting therefore their metastatic potential. In addition, the recycling mechanism of integrin alphavbeta3 was studied in breast cancer cells from primary cultures under the effect or not of the synthetic linear hexapeptide GRGDSP in this process.The results showed that incubation of the tissue fragments with the blocking RGD peptide from the beginning of the culture development inhibited the migration of the breast cancer cells out of them (SEM). Moreover, tissue fragments treated with the RGD peptide showed groups of breast cancer cells at the periphery of the tissue fragment as well as normal appearance of connective tissue of stroma (TEM).Incubation of well spread cells with the RGD peptide, after the development of the primary culture, induced roundness and shrinkage of breast cancer cells, and correlated with the distribution pattern of integrin alphavbeta3 and F-actin. More specifically, by means of immunofluorescence, in almost rounded breast cancer cells, integrin alphavbeta3 was observed as thin fingerlike clusters at the cell periphery, associated with filopodia and lamellipodia that were still adhered to the substrate. Moreover, at their cell periphery, actin cytoskeleton retained a fibrous appearance, while at the main cell body it was disorganized forming granular aggregations, as a result of focal contacts disassembly at this area, confirming that the central part of the cell body was partially detached from the substrate. In completely rounded breast cancer cells, after RGD treatment, integrin alphavbeta3 presented an intense bright diffuse staining pattern, while F-actin cytoskeleton was totally disrupted. In addition, in cancer cells of invasive ductal carcinoma grade II, RGD peptide caused stronger morphological effects compared with cancer cells of invasive ductal carcinoma grade III. In contrast, incubation of fibroadenoma cells with the RGD peptide, in which expression levels of integrin alphavbeta3 is very low, had no effect on the morphology of these cells as well as on the distribution pattern of integrin alphavbeta3 and the actin cytoskeleton.Immunogold ultrastructural localization of the integrin alphavbeta3 after RGD treatment is in agreement with the immunofluorescence results, since gold particles were observed as clusters near cell periphery with not well-formed stress fibers. Integrin alphavbeta3 was also detected in intracellular non-coated vesicles, indicating a possible clathrin-independent endocytosis of this integrin in primary breast cancer cells. Double immunofluorescence of integrin alphavbeta3 with GTPase Rab11 as well as integrin alphavbeta3 with GTPase Rab4 showed that the main recycling mechanism of integrin alphavbeta3 in primary breast cancer cells seems to be the long-loop pathway since in the majority of integrin alphavbeta3 cytoplasmic vesicles, there was co-localization with GTPase Rab11. Incubation of cancer cells with the RGD peptide caused no change in the recycling mechanism of integrin alphavbeta3, which continues to be through the long-loop pathway. However, there is an increased rate of recycling of integrin alphavbeta3 in cellular protrusions, which may serve to transfer this integrin to regions of cells that still remain attached to the substrate after the effect of the RGD peptide.Finally, RT PCR and Western immunoblotting for the integrin beta3 subunit was performed in order to examine if the change in the distribution pattern of integrin alphavbeta3, caused by RGD peptides, was also accompanied by changes in the expression of this integrin. Together with immunofluorescence and immunogold observations, RT PCR and Western immunoblotting results indicate that the altered distribution of integrin alphavbeta3 after RGD treatment is not combined with altered expression levels but probably results from lateral diffusion and trafficking of this integrin.In conclusion, the used model system of primary breast cancer cell cultures developed by the explant technique, could potentially be used in the future as an experimental tool for developing efficiently anti-integrin alphavbeta3 treatment for breast cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Georgoulis, Anastasios
  • Γεωργούλης, Αναστάσιος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/31705

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Georgoulis, Anastasios; Γεωργούλης, Αναστάσιος. Μελέτη καρκινικών κυττάρων μαστού in vitro με βιοχημικές και ανοσοϊστοχημικές μεθόδους: in vitro μελέτη του ρόλου της ιντεργκρίνης ανβ3 στην παθογένεια του καρκίνου του μαστού. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/31705